The IPO was subscribed 39.93 times in total, with the quota for qualified institutional investors receiving 3.10 times bids, and that for non-institutional investors attracting 31.59 times subscription. The employee quota was subscribed 4.82 times.
Investors, who had bid for the issue, can check the subscription status on the online portal of Link Intime India Private Ltd, the registrar to the issue. The registrar is a Sebi-registered entity qualified to act as such, which electronically processes all applications and carries out the allotment process as per the prospectus.
On Link Intime India Private Ltd’s
web portal, one needs to select the IPO whose data will be populated only when the basis of allotment is declared. One also needs to provide a PAN ID/application ID or client ID and DPID (depository participant identification) to fetch the information.
The registrar is responsible for complying with the timelines for updating the electronic credit of shares to successful applicants, dispatching and uploading of refunds, and attending to all investor-related queries after the issue is completed.
Another way of checking the IPO allotment status is via stock exchanges. To be able to do so on BSE, one can
click here.
The initiation of funds is likely by Wednesday, credit of equity shares by Thursday and listing by Friday.
Nureca, a B2C company, is engaged in the business of home healthcare and wellness products. It sells its products through online channel partners such as e-commerce players, distributors and retailers, and through its own website, drtrust.in.
Nureca classifies its product portfolio under five categories: chronic devices products, orthopedic products, mother and child products, nutrition supplements and lifestyle products.
During Covid-19, the company’s products such as oximeter, glucometer, nebulizer and BP monitor were categorized under the essential goods and their operations were not shut down during the pandemic.
